Company Filing History:
Years Active: 2008-2013
Title: Eva Möller: Innovator in Pharmaceutical Chemistry
Introduction
Eva Möller is a prominent inventor based in Södertälje, Sweden. She has made significant contributions to the field of pharmaceutical chemistry, particularly in the development of novel compounds. With a total of 4 patents to her name, her work has had a substantial impact on the industry.
Latest Patents
Her latest patents focus on a novel form of the (−)-enantiomer of 5-methoxy-2-[[(4-methoxy-3,5-dimethyl-2-pyridinyl)-methyl]sulfinyl]-1-benzimidazole, known as S-omeprazole. More specifically, these patents relate to a new form of the magnesium salt of the S-enantiomer of omeprazole trihydrate. The inventions also encompass processes for preparing this magnesium salt form and pharmaceutical compositions that include it. Additionally, new intermediates used in the preparation process are also covered in her patents.
Career Highlights
Eva Möller is currently employed at AstraZeneca AB, a leading global biopharmaceutical company. Her work at AstraZeneca has allowed her to collaborate with other talented professionals in the field, enhancing her contributions to pharmaceutical innovations.
Collaborations
Some of her notable coworkers include Hanna Cotton and Anders Kronström. Their collaborative efforts have further advanced the research and development of new pharmaceutical products.
Conclusion
Eva Möller is a distinguished inventor whose work in pharmaceutical chemistry continues to influence the industry. Her innovative patents and collaborations reflect her commitment to advancing healthcare solutions.